Broad-Spectrum Kinase Inhibitor CTX0294885: Revolutionizing Kinome Profiling and Targeted Therapy Development
Discover the power of CTX-0294885, a novel broad-spectrum kinase inhibitor. Unlock new avenues in kinome profiling and advance targeted therapeutic strategies for diseases like cancer. Available from reputable suppliers in China for your research needs.
Get a Quote & SampleUnlock Precision in Kinase Research with a Trusted Supplier
High-Purity Broad-Spectrum Kinase Inhibitor
As a leading manufacturer and supplier of specialized chemicals, we offer CTX-0294885 (CAS 1439934-41-4), a meticulously synthesized broad-spectrum kinase inhibitor. Its high purity (>98%) ensures reliable results in your research, making it an indispensable tool for those looking to buy this critical pharmaceutical intermediate.
- Advanced Kinome Profiling: Utilize this powerful reagent for in-depth analysis of kinome signaling networks, crucial for understanding cellular processes.
- Targeted Therapy Facilitation: CTX-0294885 aids in the identification of protein kinases, paving the way for developing more effective targeted therapeutic strategies.
- Exceptional Purity: Source with confidence from a reliable manufacturer in China, ensuring >98% purity for consistent and reproducible research outcomes.
- Cost-Effective Procurement: Inquire about our competitive pricing and purchase options for bulk quantities, serving your ongoing research and development needs.
Key Advantages for Your Research and Development
Comprehensive Kinase Inhibition
CTX-0294885 demonstrates inhibitory activity against a broad range of kinases in vitro, making it a versatile tool for researchers studying complex signaling pathways.
Enhanced Kinase Identification
Its application in affinity purification, coupled with LC-MS/MS, has led to the identification of a significant number of protein kinases, including members of the AKT family previously undetected by other inhibitors.
Support for Targeted Therapeutics
As a critical pharmaceutical intermediate, CTX-0294885 is instrumental in the development of targeted therapeutic strategies, particularly in oncology, offering a pathway to improved patient outcomes.
Diverse Applications in Scientific Discovery
Kinome Profiling
Leverage CTX-0294885 for comprehensive analysis of kinase activities, enabling a deeper understanding of cellular regulation and disease mechanisms.
Cancer Research
This inhibitor is invaluable for studies focused on cancer development and progression, offering a potential avenue for discovering novel anti-cancer therapies.
Targeted Drug Development
As a key intermediate, it supports the R&D of targeted therapies, where specific kinase inhibition is crucial for therapeutic efficacy.
Proteomics and Mass Spectrometry
Its use in affinity purification techniques makes it a vital component for mass spectrometry-based kinome profiling.